PHARM RES-DORDR 润色咨询

PHARMACEUTICAL RESEARCH

出版年份：1984 年文章数：5840 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-04-02 匿名用户

    在药学领域还挺不错的刊物，不知为何属于4区

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-01-02 匿名用户

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-01-02 匿名用户

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：这个杂志挺难发的啊！同意楼上观点

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-12-15 thanks

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-11-26 ms3041982178615389

    感觉效率有点慢，从投稿到接受历时5个月~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-05-06 匿名用户

    最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-05-26 匿名用户

    今年IF或将过5分

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-07-01 cani

    拒稿率很高，分不高但并不容易

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-30 匿名用户

    文章内容充实！

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=502119, encodeId=2cc350211974, content=在药学领域还挺不错的刊物，不知为何属于4区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 02 00:23:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500422, encodeId=ad5050042209, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：对待有创新性的药物研究方法比较认可，但投稿周期比较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:17:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500421, encodeId=0b8a5004218d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：这个杂志挺难发的啊！同意楼上观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jan 02 16:13:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500210, encodeId=9c235002104d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：杂志论文收录要求很高，做的内容要新颖，工作量要大，对论文撰写要求也是比较高,绝对称得上药学一流杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=thanks, createdTime=Sun Dec 15 17:57:00 CST 2013, time=2013-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=829481, encodeId=b85582948187, content=感觉效率有点慢，从投稿到接受历时5个月~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Tue Nov 26 18:12:00 CST 2013, time=2013-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495533, encodeId=4dea49553346, content=最近中了一篇，本来投JH的，实验意义还行，不过内容不够精细。修回到接受一个半月，感觉时间还是蛮久的。不过后面就快了，接受后两周，pubmed就出来了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon May 06 11:02:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488612, encodeId=be02488612b6, content=今年IF或将过5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat May 26 23:28:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483053, encodeId=34ba48305337, content=拒稿率很高，分不高但并不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cani, createdTime=Fri Jul 01 16:27:00 CST 2011, time=2011-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483015, encodeId=308b4830158d, content=文章内容充实！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 30 14:31:00 CST 2011, time=2011-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481418, encodeId=24e3481418d7, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦，明年会不会再涨？

    0

共26条页码: 2/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分